+965 25332330
+965 90094424
4:30 - 9:30 pm (weekdays)
Sat 10:30-1:30 pm, Fri closed

News & Articles


Omalizumab improves efficacy of oral immunotherapy for multiple food allergies

ombination allows more than 80 percent of children to safely consume at least two foods to which they were allergic. Read More


New NIH consortium award to enhance clinical trials for Alzheimer’s disease, related dementias

Effort streamlines study infrastructure to improve recruitment diversity, advance research. Read More


New forecast shows 6 million with Alzheimer’s disease, cognitive impairment

The numbers will more than double to 15 million by 2060. Read More


Gene-based Zika vaccine is safe and immunogenic in healthy adults

Vaccine developed by NIH scientists shows promise in Phase 1 testing. Read More


Trials show inactivated Zika virus vaccine is safe and immunogenic

Results support further clinical development. Read More


NIH Statement on World AIDS Day 2017

After 30 years of marking progress against HIV, we are closer than ever to the beginning of the end of the HIV/AIDS pandemic. Read More


Allergens widespread in largest study of U.S. homes

Over 90 percent of homes had three or more detectable allergens. Read More


NIH and partners launch HIV vaccine efficacy study

Public-private partnership begins clinical trial in sub-Saharan Africa. Read More


NIH launches HIV prevention trial of long-acting injectable medication in sexually active women

Study to test efficacy, safety of injectable cabotegravir compared with daily oral PrEP. Read More


Combination HIV prevention reduces new infections by 42 percent in Ugandan district

NIH-supported study provides evidence for implementing approach broadly. Read More